1/31
07:03 pm
nvs
Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap [Yahoo! Finance]
Low
Report
Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap [Yahoo! Finance]
1/31
07:03 pm
nvs
Why Analysts Are Closely Watching Novartis AG (NVS) [Yahoo! Finance]
Low
Report
Why Analysts Are Closely Watching Novartis AG (NVS) [Yahoo! Finance]
1/29
09:30 am
nvs
NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"
Low
Report
NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"
1/28
07:02 pm
nvs
Breakthrough Therapy Status For Ianalumab Could Be A Game Changer For Novartis (SWX:NOVN) [Yahoo! Finance]
Low
Report
Breakthrough Therapy Status For Ianalumab Could Be A Game Changer For Novartis (SWX:NOVN) [Yahoo! Finance]
1/28
07:02 pm
nvs
Eaton Vance Worldwide Health Sciences Fund Reduces Stake in Novo Nordisk AS by 49.25% [Yahoo! Finance]
Low
Report
Eaton Vance Worldwide Health Sciences Fund Reduces Stake in Novo Nordisk AS by 49.25% [Yahoo! Finance]
1/28
10:32 am
nvs
Jim Cramer is Optimistic About Novartis' (NVS) Cancer Drug [Yahoo! Finance]
Low
Report
Jim Cramer is Optimistic About Novartis' (NVS) Cancer Drug [Yahoo! Finance]
1/27
08:57 am
nvs
Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back [Yahoo! Finance]
Low
Report
Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back [Yahoo! Finance]
1/27
05:12 am
nvs
Novartis (NYSE:NVS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Novartis (NYSE:NVS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/26
01:43 pm
nvs
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026? [Yahoo! Finance]
Low
Report
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026? [Yahoo! Finance]
1/25
07:31 pm
nvs
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a) [Yahoo! Finance]
Low
Report
Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a) [Yahoo! Finance]
1/21
07:04 pm
nvs
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer [Yahoo! Finance]
Low
Report
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer [Yahoo! Finance]
1/21
05:56 pm
nvs
Cystinosis Market to Grow at a Substantial Growth Rate of 5.1% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
Low
Report
Cystinosis Market to Grow at a Substantial Growth Rate of 5.1% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
1/20
05:27 am
nvs
Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub [Yahoo! Finance]
Low
Report
Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub [Yahoo! Finance]
1/20
05:12 am
nvs
Possible U.S. deal and regional manufacturing to shield Novartis from tariffs, CEO tells CNBC [CNBC]
Low
Report
Possible U.S. deal and regional manufacturing to shield Novartis from tariffs, CEO tells CNBC [CNBC]
1/19
08:06 pm
nvs
They left pharma and fine dining to open a cozy bakery. Early mornings and 16-hour days are a small price to pay. [Business Insider]
Low
Report
They left pharma and fine dining to open a cozy bakery. Early mornings and 16-hour days are a small price to pay. [Business Insider]
1/19
02:52 pm
nvs
Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease [Yahoo! Finance]
Low
Report
Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease [Yahoo! Finance]
1/19
04:17 am
nvs
$15.5 Bn Next Generation Drug Conjugates Market Trends and Global Forecasts, 2035 [Yahoo! Finance]
Low
Report
$15.5 Bn Next Generation Drug Conjugates Market Trends and Global Forecasts, 2035 [Yahoo! Finance]
1/16
03:05 pm
nvs
Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
1/15
05:52 pm
nvs
Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
Low
Report
Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
1/14
08:53 pm
nvs
JPM26: Vor Bio narrows focus to two-indication strategy [Yahoo! Finance]
Low
Report
JPM26: Vor Bio narrows focus to two-indication strategy [Yahoo! Finance]
1/13
07:31 pm
nvs
Novartis CEO Dr. Vasant Narasimhan sits down with Jim Cramer [CNBC]
Low
Report
Novartis CEO Dr. Vasant Narasimhan sits down with Jim Cramer [CNBC]
1/13
06:18 pm
nvs
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight [Yahoo! Finance]
1/13
10:31 am
nvs
Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth [Yahoo! Finance]
Low
Report
Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth [Yahoo! Finance]
1/12
09:52 am
nvs
SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs [Yahoo! Finance]
Low
Report
SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs [Yahoo! Finance]
1/12
08:55 am
nvs
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease [Yahoo! Finance]
Low
Report
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease [Yahoo! Finance]